Italy: Novartis loses appeal of collusion fines
Switzerland-based pharmaceutical company Novartis announced Tuesday that it has lost its appeal of a competition fine issued by Italian officials
Switzerland-based pharmaceutical company Novartis announced Tuesday that it has lost its appeal of a competition fine issued by Italian officials
Two more executives of Japanese car parts manufacturers have reportedly agreed to plead guilty to allegations of a conspiracy to
Quinn Emanuel has announced the addition of a new competition litigator to its Global Competition Group. Antitrust lawyer Boris Bronfentrinker
EU competition officials are now considering their next move following Russian President Vladimir Putin’s unexpected announcement that the nation would
An antitrust partner at Freshfields Burckhaus Deringer is reportedly in the running to take a soon-to-be open position as the
The mastermind behind Apple’s eBook business strategy offered an interview two weeks ahead of the company’s appeal of a ruling
A former Department of Justice antitrust and Federal Communications Commission cybersecurity official has reportedly joined Akin Gump. David Turetsky is
European Commission President Jean Claude Juncker has vowed to fast-track legislation that would aim to curb tax breaks offered to
Posted by Social Science Research Network Determinants of Pharmaceutical Review, Success and Duration – Rosa M. Abrantes-Metz (Global Economics Group,
The Competition Commission of India has suggested changes to the proposed merger of pharmaceutical giants Sun Pharma and Ranbaxy after
© Competition Policy International 2024